Missing Med Deepens Trump Health Mystery

A political figure with a serious expression standing outdoors near the White House

A drug that quietly shaped one of the most recognizable hairstyles in American political history has vanished from Donald Trump’s medical records, and nobody in his inner circle is explaining why.

Story Snapshot

Trump was reported in 2017 to be taking finasteride, the hair-loss drug sold under the brand name Propecia, as part of his regular medication regimen.
Finasteride no longer appears in Trump’s current medical disclosures, with no official explanation for its absence.
The drug carries a well-documented and controversial side-effect profile, including allegations of sexual dysfunction and memory problems.
The gap between past reporting and current records raises legitimate questions about the completeness of presidential health transparency.

What the 2017 Reports Actually Said About Trump and Propecia

Back in March 2017, the medical news outlet STAT published a piece titled “Why I’d never take the hair loss drug President Trump uses,” naming Propecia explicitly as part of Trump’s reported medication routine. ^[1] The story was tied to Trump’s then-physician, Harold N. Bornstein, a New York doctor who had become famous for his unusually effusive letters about Trump’s health. The reporting was widely picked up and repeated across major outlets, cementing the finasteride claim in the public record. ^[4]

Here is the critical distinction that often gets lost: STAT described finasteride as part of Trump’s “reported regimen,” not as a verified prescription pulled from a pharmacy record or a clinical chart. ^[1] That is not a trivial difference. Reported use and confirmed use are two separate things, and the media’s tendency to treat the former as the latter is a recurring problem in political health coverage. That said, the reporting was specific, named, and sourced to a physician in Trump’s own orbit, which gives it considerably more weight than anonymous speculation.

Finasteride’s Side Effect Profile Is the Real Reason This Story Has Legs

Finasteride is not a benign vitamin. Merck, the drug’s manufacturer, has faced significant litigation over claims that Propecia causes lasting sexual side effects and cognitive impairment in some users. ^[1] Those lawsuits have kept the drug in the news for years and created a powerful reputational incentive for any public figure, especially one as image-conscious as Trump, to quietly distance himself from the medication. Trump himself reportedly told NBC’s Chuck Todd that Propecia worked well and had no negative effects on him, a remarkably candid on-the-record endorsement that is now awkward given the drug’s current absence from his health disclosures. ^[2]

That public endorsement matters. When a sitting president publicly champions a drug with a contested safety profile and then that drug disappears from his medical records without explanation, the public has a reasonable interest in understanding what changed. Did he stop taking it? Did a physician advise discontinuation? Is the omission deliberate? These are not tabloid questions. They are the kind of questions any informed citizen should want answered about the health management of the nation’s chief executive.

The Broader Problem With Presidential Health Transparency

Presidential medical disclosure in the United States operates on an honor system with no enforcement mechanism. Presidents release what their physicians choose to summarize, and those summaries are not subject to independent audit. The result is a long history of selective disclosure across administrations of both parties. What makes the finasteride gap notable is not that a president may have stopped taking a medication, but that a previously reported drug simply evaporated from the record with no acknowledgment that anything changed at all. ^[3]

For years, Trump took a hair-loss drug — Propecia (finasteride).

Now it’s no longer on his medical reports.

I asked the White House if Trump still uses it, and officials said they’re not obligated to disclose all his medications. https://t.co/80QluMs2Ap

— Dan Diamond (@ddiamond) June 4, 2026

Washington Post reporter Dan Diamond, who covers health policy and has tracked Trump’s medical disclosures closely, noted the absence publicly and confirmed he had sought comment without receiving a satisfying answer. ^[3] That is exactly the kind of journalism that keeps powerful institutions accountable, and the non-response from Trump’s team is itself informative. Silence on a specific factual question from a press office that is rarely shy about pushing back is a data point worth taking seriously. The absence of finasteride from Trump’s current medical summary may ultimately mean nothing medically significant. But the absence of any explanation for that absence is a transparency failure, plain and simple.